Theraclion Earnings Estimate
Theraclion Earnings per Share Projection vs Actual
About Theraclion Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Theraclion earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Theraclion estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Theraclion fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. The company was incorporated in 2004 and is based in Malakoff, France. Theraclion operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 24 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Theraclion Pink Sheet
Theraclion financial ratios help investors to determine whether Theraclion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theraclion with respect to the benefits of owning Theraclion security.